Latest SPAC News
Why Oklo Stock Dropped on Thursday
2026-01-29 3:20 PM   OKLO
The Motley Fool: DOE is asking states if they would like to host Nuclear Lifecycle Innovation Campuses" within their territory. These sites would research fuel fabrication, enrichment, reprocessing used nuclear fuel, and disposition of waste.
 
Here is What to Know Beyond Why Symbotic Inc. (SYM) is a Trending Stock
2026-01-29 3:01 PM   SYM
Zacks Investment Research: SYMBOTIC INC (SYM) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
 
3 Rare Earth Stocks to Watch in 2026
2026-01-29 2:45 PM   MP,TMC,USAR
The Motley Fool: MP Materials operates one of the two large-scale light rare-earth production facilities outside China. TMC aims to mine polymetallic nodules on the seabed, which are rich in certain critical minerals.
 
GIBO Upgrades GIBO Create for Scalable AIGC Short Film Production, Expanding Capabilities Across Partner Ecosystem
2026-01-29 2:00 PM   GIBO
PRNewsWire: KUALA LUMPUR, Malaysia, Jan. 29, 2026 /PRNewswire/ -- GIBO Holdings Ltd. (NASDAQ: GIBO) today announced a major upgrade to GIBO Create, its AI-powered creative production suite, enabling large-scale, high-efficiency short film generation and deployment.
 
ESS Tech Awarded $9.9 Million Contract from Concurrent Technologies Corporation and U.S. Air Force Research Laboratory
2026-01-29 1:40 PM   GWH
Business Wire: WILSONVILLE, Ore.--(BUSINESS WIRE)--ESS Tech Awarded $9.9 Million Contract from Concurrent Technologies Corporation and U.S. Air Force Research Laboratory.
 
YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy
2026-01-29 1:30 PM   YDES
GlobeNewsWire: TAIWAN, Jan. 29, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio Ltd” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced it has entered into a binding Letter of Intent (the “LoI”) to acquire all shares, assets, and business of Safe Save Medical Cell Sciences & Technology Co., Ltd. ("SSMC"), a Taiwan-based dendritic cell immunotherapy platform.
 
Fold Chairman and CEO, Will Reeves, Publishes Letter to Fold Customers
2026-01-29 1:15 PM   FLD
GlobeNewsWire: PHOENIX, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Yesterday  Fold Holdings, Inc. (NASDAQ: FLD) (“Fold” or the “Company”), a Bitcoin financial services company making it easy for individuals to earn, save, and spend bitcoin through everyday financial tools, filed an 8K with a letter from Chairman and CEO, Will Reeves, to Fold customers. A copy of that letter follows below.
 
VSee and DocBox Announce Strategic Partnership to Launch the First Augmented Intelligence Platform for Virtual ICU
2026-01-29 1:11 PM   VSEE
Accesswire: Creating a scalable, AI‑native Virtual ICU platform that drives new recurring revenue and enterprise value. SAN JOSE, CALIFORNIA / ACCESS Newswire / January 29, 2026 / VSee Health, Inc. (Nasdaq:VSEE), a leader in enterprise telehealth and AI-powered virtual care, today announced a strategic partnership with DocBox, the first Augmented Intelligence platform for critical care, to create a next-generation Virtual ICU operating system for hospitals worldwide.
 
Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026
2026-01-29 1:00 PM   PFSA
GlobeNewsWire: Study conducted at US sites evaluates LumeeTM in peripheral artery disease (PAD) patients BERKELEY, Calif, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation technology platform enabling the continuous monitoring of an individual's biochemistry, announces the presentation of positive US-study clinical trial results at Leipzig Interventional Course in Leipgzig, Germany on Wednesday, January 28, 2026.  The study, conducted at the University of California San Francisco, San Francisco VA Medical Center, and San Francisco General Hospital, showed Lumee oxygen tissue monitoring is a safe and effective method for long term monitoring of peripheral artery disease (PAD) patients.
 
Alpha Modus Partners with Prepay Nation to Supercharge Prepaid Access for the Underbanked
2026-01-29 12:30 PM   AMOD
GlobeNewsWire: Alpha Modus partners with Prepay Nation to expand prepaid mobile, gift card, and digital value services through the Alpha Cash app for underbanked consumer
 
USA Rare Earth Announces Closing of $1.5 Billion PIPE Financing
2026-01-29 12:01 PM   USAR
GlobeNewsWire: STILLWATER, Okla., Jan. 29, 2026 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company), today announced the closing of its previously announced private investment in public equity (PIPE) financing.
 
SES AI Announces Date of Conference Call for Fourth Quarter 2025 Results
2026-01-29 12:00 PM   SES
Business Wire: WOBURN, Mass.--(BUSINESS WIRE)---- $SES #AI--SES AI Corporation (“SES AI”) (NYSE: SES), a global leader in the development and manufacturing of AI-enhanced high-performance Li-Metal and Li-ion batteries, today announced it will release its 2025 fourth quarter financial results after market close on Wednesday, March 4, 2026. The Company will hold a conference call on Wednesday, March 4, 2026, at 5:00 p.m. ET. A webcast of the live conference call will be available through SES's Investor Relations website, ht.
 
Top 3 Consumer Stocks You'll Regret Missing This Quarter This Month
2026-01-29 11:33 AM   CVNA,KSS,RSI
Benzinga: The most oversold stocks in the consumer discretionary sector presents an opportunity to buy into undervalued companies.
 
Forget 2025: These 2 Growth Stocks Could Soar in 2026
2026-01-29 10:55 AM   DKNG,RXRX
The Motley Fool: DraftKings' bulls were thrown an unexpected curveball, but this new competition doesn't carry the same brand-name cache. After years of development, Recursion Pharmaceuticals' AI-powered drug discovery technology should finally, firmly start proving its true value.
 
This Popular Artificial Intelligence (AI) Stock Plunged by 49% in 2025. Here's What Could Happen Next.
2026-01-29 10:26 AM   SOUN
The Motley Fool: SoundHound AI's conversational artificial intelligence (AI) software is used by some of the biggest brands in the world. The company will report its official operating results for 2025 in February, which will likely show that its revenue more than doubled for the year.
 
Robinhood Soared by 204% in 2025, but Here's Another Financial Stock to Buy in 2026
2026-01-29 10:05 AM   SOFI
The Motley Fool: SoFi continues to add record numbers of customers to its platform. It's growing much faster than the traditional, large banks.
 
Blue Owl Capital Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - OWL
2026-01-29 9:34 AM   OWL
PRNewsWire: LOS ANGELES, Jan. 29, 2026 /PRNewswire/ -- The DJS Law Group  reminds investors of a class action lawsuit against Blue Owl Capital Inc. ("Blue Owl " or "the Company") (NYSE: OWL ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of OWL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.
 
Joby Aviation Stock Plunges. This Is Why.
2026-01-29 9:03 AM   JOBY
Barrons: The electric takeoff and landing aircraft maker is raising $1 billion by selling common stock and convertible bonds.
 
Joby Aviation Prices Upsized Offering of Primary Common Stock and Upsized Offering of Convertible Senior Notes
2026-01-29 8:48 AM   JOBY
Business Wire: SANTA CRUZ, Calif.--(BUSINESS WIRE)---- $JOBY--Joby Aviation, Inc. (NYSE: JOBY), a company developing electric air taxis for commercial passenger service, today announced the pricing of its concurrent public offerings of $600.0 million aggregate principal amount of 0.75% convertible senior notes due 2032 (the “notes”) (such offering, the “note offering”) and 52,863,437 shares of Joby's common stock, $0.0001 par value per share (the “common stock”), at a public offering price of $11.35 per share (such off.
 
The Motley Fool Interviews Redwire CEO Peter Cannito
2026-01-29 6:37 AM   RDW
The Motley Fool: In this podcast, Motley Fool contributor Lou Whiteman talks with Peter Cannito about the business of space and the business of Redwire.
 


Jump to a SPAC Profile
Tracking

1626 SPACs

funded at over

$246 Billion

SPAC Calendar

7448 Events

and counting...

64 This Month

Important Notice

We use cookies for functional, analytical, and advertising purposes. By using our service you agree to our Disclaimer, Terms of Service, and Privacy Policy.